123 related articles for article (PubMed ID: 34533030)
41. Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer.
Seo EJ; Kim DK; Jang IH; Choi EJ; Shin SH; Lee SI; Kwon SM; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Aug; 7(34):55624-55638. PubMed ID: 27489349
[TBL] [Abstract][Full Text] [Related]
42. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.
Yang M; Liang Z; Yang M; Jia Y; Yang G; He Y; Li X; Gu HF; Zheng H; Zhu Z; Li L
FASEB J; 2019 Sep; 33(9):10077-10088. PubMed ID: 31237775
[TBL] [Abstract][Full Text] [Related]
43. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines.
Drenzek JG; Seiler NL; Jaskula-Sztul R; Rausch MM; Rose SL
Gynecol Oncol; 2011 Aug; 122(2):396-401. PubMed ID: 21616523
[TBL] [Abstract][Full Text] [Related]
44. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
Zhang W; Deng ZL; Chen L; Zuo GW; Luo Q; Shi Q; Zhang BQ; Wagner ER; Rastegar F; Kim SH; Jiang W; Shen J; Huang E; Gao Y; Gao JL; Zhou JZ; Luo J; Huang J; Luo X; Bi Y; Su Y; Yang K; Liu H; Luu HH; Haydon RC; He TC; He BC
PLoS One; 2010 Jul; 5(7):e11917. PubMed ID: 20689834
[TBL] [Abstract][Full Text] [Related]
45. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury.
Addante A; Roncero C; Almalé L; Lazcanoiturburu N; García-Álvaro M; Fernández M; Sanz J; Hammad S; Nwosu ZC; Lee SJ; Fabregat I; Dooley S; Ten Dijke P; Herrera B; Sánchez A
Liver Int; 2018 Sep; 38(9):1664-1675. PubMed ID: 29751359
[TBL] [Abstract][Full Text] [Related]
46. Bone morphogenetic protein 9 is a potential tumor suppressor in osteosarcoma.
Liang J; Zhang J; Chen F; Lian Z; Dong Y; Lu N; Jia Y
Int J Clin Exp Pathol; 2017; 10(11):11030-11036. PubMed ID: 31966448
[TBL] [Abstract][Full Text] [Related]
47. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-155 inhibits the osteogenic differentiation of mesenchymal stem cells induced by BMP9 via downregulation of BMP signaling pathway.
Liu H; Zhong L; Yuan T; Chen S; Zhou Y; An L; Guo Y; Fan M; Li Y; Sun Y; Li W; Shi Q; Weng Y
Int J Mol Med; 2018 Jun; 41(6):3379-3393. PubMed ID: 29512689
[TBL] [Abstract][Full Text] [Related]
49. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
Zhao J; Wang Y; Mu C; Xu Y; Sang J
Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
[TBL] [Abstract][Full Text] [Related]
50. The proliferation and migration of atherosclerosis-related HVSMCs were inhibited by downregulation of lncRNA XIST via regulation of the miR-761/BMP9 axis.
Mo L; Jiang HB; Tian GR; Lu GJ
Kaohsiung J Med Sci; 2022 Jan; 38(1):18-29. PubMed ID: 34595819
[TBL] [Abstract][Full Text] [Related]
51. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
52. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
[TBL] [Abstract][Full Text] [Related]
53. BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.
Gou L; Liu M; Xia J; Wan Q; Jiang Y; Sun S; Tang M; Zhou L; He T; Zhang Y
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642505
[TBL] [Abstract][Full Text] [Related]
54. FAK mediates BMP9-induced osteogenic differentiation via Wnt and MAPK signaling pathway in synovial mesenchymal stem cells.
Zheng W; Gu X; Sun X; Wu Q; Dan H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2641-2649. PubMed ID: 31240956
[No Abstract] [Full Text] [Related]
55. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
56. An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706.
Lu Z; Liu H; Xue L; Xu P; Gong T; Hou G
Int J Oncol; 2008 Mar; 32(3):643-51. PubMed ID: 18292942
[TBL] [Abstract][Full Text] [Related]
57. BMP9 inhibits the growth of breast cancer cells by downregulation of the PI3K/Akt signaling pathway.
Li S; Dai H; He Y; Peng S; Zhu T; Wu Y; Li C; Wang K
Oncol Rep; 2018 Sep; 40(3):1743-1751. PubMed ID: 30015950
[TBL] [Abstract][Full Text] [Related]
58. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway.
Zhou XY; Shu XM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):522-529. PubMed ID: 30720159
[TBL] [Abstract][Full Text] [Related]
59. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
Bai L; Wang A; Zhang Y; Xu X; Zhang X
Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
[TBL] [Abstract][Full Text] [Related]
60. P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
Zhao Y; Song T; Wang W; Wang J; He J; Wu N; Tang M; He B; Luo J
PLoS One; 2012; 7(8):e43383. PubMed ID: 22912865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
